Relevant to: All Prescription Drug Plans, Medicare Advantage-Prescription Drug Plans, Section 1876 Cost Plans, Medicare-Medicaid Plans, and PACE Plans
The purpose of this memorandum is to provide Part D sponsors with instructions as they prepare to submit bids for CY 2025. This memorandum includes annual programmatic updates and serves to supplement the forthcoming Final CY 2025 Part D Redesign Program Instructions document which will include program instructions for 2025 for the implementation of provisions enacted in the Inflation Reduction Act (IRA, P.L. 117-169), on August 16, 2022.